Juno Therapeutics (JUNO) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free JUNO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineZelda Williams did extensive 'academic study' of '80s films before helming 'Lisa Frankenstein'yahoo.com - April 9 at 1:06 PMMichigan AP names Trey McKenney of Orchard Lake St. Mary's Division 1 basketball Player of the Yearmsn.com - March 30 at 3:22 PMXcell Biosciences Announces New Scientific and Business Advisory Boardfinance.yahoo.com - March 27 at 9:52 AMOut of the lab and into the factorybizjournals.com - March 18 at 3:42 AMEFTR eFFECTOR Therapeutics, Inc.seekingalpha.com - March 16 at 10:53 AMMotorcyclist killed in fatal accident near Manatee Avenue, Bradenton police saymsn.com - March 15 at 12:50 AMWhat we know about Jeff Bezos’ net worthmsn.com - February 21 at 8:51 PMMantle Cell Lymphoma Therapeutics Market to Reach $3.29 Billion by 2028 with Innovations in Targeted Therapiesuk.finance.yahoo.com - February 8 at 1:16 PMZelda Williams Says She Was 'Fascinated’ by Late Dad Robin Williams' Career from Young Ageca.news.yahoo.com - January 31 at 2:05 PMHow Zelda Williams Found Humor in Traumamsn.com - January 31 at 9:04 AMCovid cases in Stoke-on-Trent right now as 'Juno' strain hits UKmsn.com - January 16 at 7:56 AMVaginitis Therapeutics Global Market Landscape Analysis 2023-2030: New Treatment Avenues and Key Company Innovations Propel the Industryuk.finance.yahoo.com - January 11 at 7:59 PMAutolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directorsfinance.yahoo.com - January 10 at 8:35 AMBiotech Industry Veterans Jeff Jonas and Al Robichaud Join Cure Ventures as Partnerstmcnet.com - January 8 at 8:49 AMWeek In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4Bseekingalpha.com - January 7 at 8:20 AMTwo dead in McDermot Avenue fire, cause under investigationmsn.com - December 22 at 4:48 AMElliot Page: Juno actor to divorce Emma Portnerbbc.com - December 12 at 12:17 AMFirst Patient Enrolled in the PUERTA Phase 2A ARDS Clinical Trial: Treatment with Aqualung Therapeutics ALT-100 mAbfinance.yahoo.com - December 5 at 8:49 AMSeattle Children's launches BrainChild Bio to accelerate CAR T-cell therapies for children with brain tumorsfinance.yahoo.com - December 5 at 8:49 AMTScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officermarkets.businessinsider.com - December 4 at 8:46 AMRepairon Appoints Co-Founder Dr. Lothar Germeroth as Chief Executive Officertmcnet.com - September 15 at 2:34 PMCARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officerfinance.yahoo.com - September 12 at 9:13 AMNotch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle officesmsn.com - August 28 at 6:00 PMAffini-T Therapeutics shutting down Seattle labmsn.com - July 20 at 2:43 PMADC Therapeutics Announces Evolution of Board of Directorsfinance.yahoo.com - June 15 at 9:18 AMElliot Page writes about relationship with ‘Juno’ co-star Olivia Thirlby in his new memoiryahoo.com - June 15 at 4:18 AMSpeed Read: Elliot Page on Secret ‘Juno’ Hookups, Double Dates With Leonardo DiCaprio and Transphobic Violenceyahoo.com - June 14 at 3:42 PMElliot Page on Juno, Hollywood’s dark side and coming out twice: ‘Living my life was more important than being in movies’theguardian.com - June 14 at 9:30 AMCancer-fighting biotech startup Indapta lands $30M with assist from FDAbizjournals.com - May 18 at 10:58 AM2030, Multiple Myeloma Therapeutics Market: Trend & Outlookmarketwatch.com - May 13 at 3:45 PMChinook Therapeutics, Inc.: Chinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updatesfinanznachrichten.de - May 10 at 7:08 AM2023-2031 "CAR T-Cell Therapy Market" Development: Key Players Analysis and Innovative Growth Opportunitiesmarketwatch.com - May 10 at 7:08 AM2023-2030 Multiple Myeloma Therapeutics Market Size (Growth and Outlook) includes Sales Channel and Regional Analysis | with [101 Pages]marketwatch.com - May 5 at 4:11 PMCAR T-Cell Therapy Market Share and Forecast till 2030marketwatch.com - May 5 at 8:34 AMGlobal Indolent Lymphoma Treatment Market by Size, Trend & New Technology till 2023-2030marketwatch.com - May 3 at 7:58 AMJuno review: Digital high-yield checking account with cash back rewardsbusinessinsider.com - April 29 at 9:01 AMMultiple Myeloma Therapeutics Market Top Key Players by 2030marketwatch.com - April 29 at 1:06 AMCAR T-Cell Therapy Market Research Analysis 2023-2031marketwatch.com - April 28 at 10:05 AMNeuroblastoma Treatment Market Insights and Segmentation Until 2031marketwatch.com - April 24 at 8:25 AMCAR T-Cell Therapy Market 2023 Global Report Insights 2029marketwatch.com - April 19 at 8:34 AMFormer Eliem CEO Bob Azelby joins board of Chinook Therapeuticsbizjournals.com - April 17 at 4:31 AMCentury Therapeutics, Inc.: Century Therapeutics Announces Leadership Changesfinanznachrichten.de - April 12 at 10:20 AMTune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counselfinance.yahoo.com - April 10 at 10:38 AMAnHeart Therapeutics Appoints Edward Lang Jr. as Chief Business Officerfinance.yahoo.com - April 3 at 9:30 AMCAR-T Therapy Market Analysis by Global Report Research, 2029marketwatch.com - March 30 at 12:29 PMMultiple Myeloma Therapeutics Market | Newsest Researchmarketwatch.com - March 27 at 7:58 AMGlobal Multiple Myeloma Therapeutics Market In-Depth Analysis, Business Forecast, and Dynamics 2023 – 2030 By VMReportsmarketwatch.com - March 26 at 5:34 AM2023 to 2028 CAR T-Cell Therapy Market Forecasting Future Growth Outlookmarketwatch.com - March 17 at 9:21 AM2029 Forecast CAR-T Therapy Market 2023 by Growth Rate, Sparked Innovation with Top Playersmarketwatch.com - March 14 at 6:56 AMImmune Repertoire Sequencing Market 2023-2028 New Review by Competitor Analysis and Recent Developmentmarketwatch.com - March 11 at 8:04 AM Get Juno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry JUNO Media Mentions By Week JUNO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JUNO News Sentiment▼0.000.52▲Average News Sentiment JUNO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JUNO Articles This Week▼00▲JUNO Articles Average Week Get Juno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JUNO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Juno Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
